Search results for Landogrozumab
Landogrozumab Biosimilar – Anti-MSTN, GDF8 mAb – Research Grade, ProteoGenix, PX-TA1403
Description of Landogrozumab Biosimilar - Anti-MSTN, GDF8 mAb - Research Grade General information on Anti-MSTN/GDF8[Homo sapiens] (Landogrozumab) Monoclonal Antibody Landogrozumab has been investigated for the treatment of Advanced Cancer, Muscular Atrophy, and Pancreatic Cancer.
Host
Reactivity
Applications
Conjugation
Landogrozumab, Abbexa, abx831362
Landogrozumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting MSTN/GDF8, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Landogrozumab has been used in trials studying the treatment of Advanced Cancer, Muscular Atrophy, and Pancreatic Cancer.
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Landogrozumab Biosimilar - Research Grade, ichor.bio, ICH5624
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Research Grade Landogrozumab (HT343016), abinScience, HT343016
Host
Humanized
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.